A woman in her mid-40s walks out of a doctor’s appointment with a list of prescriptions she cannot afford, for a condition the medical establishment barely acknowledges or receives training on, with no insurance to cover any of it, for a body that is failing apart in ways nobody warned her about. She is not asking for a spa day. She is asking for functioning health care. And the answer, in 2026, is still essentially: figure it out yourself.
She is not poor enough for Medicaid. She is not old enough for Medicare. She is not wealthy enough for the boutique telehealth clinics flooding her Instagram feed. She is in the gray area, that income purgatory where a woman earns just enough to disqualify her from every safety net but nowhere near enough to pay for the care she needs. In 2026, that gray area is wider than it has ever been.
Menopause affects more than 750 million women worldwide, and approximately 2 million women in the United States enter it every year. “Women outlive the lifespan of our ovaries,” said Kelly Casperson, MD, a urologist based in the Pacific Northwest and a leading voice for women’s health rights. What follows is that biological reality is far more dangerous than the cultural shorthand of hot flashes and mood swings suggests. Declining estrogen is linked to measurable cognitive impairment that can mimic early-onset dementia, accelerated cardiovascular disease risk, gut microbiome disruption that destabilizes digestion and metabolism, rapid collagen loss, frozen shoulders caused by estrogen-driven inflammation that can immobilize an arm for up to two years, air hunger that leaves women gasping at their desks for no apparent reason, new-onset autoimmune flares, and the unmasking of previously undiagnosed ADHD and autism as the dopamine regulation that compensated for these conditions for decades collapses alongside estrogen levels. A 2025 systematic review published in Women’s Health found that 84% of high-quality studies showed an association between the menopausal transition and increased suicidality, with many affected women reporting no prior history of mental illness.
Dismissed, misdiagnosed, and left untreated
“Women have been taught to fear their hormones and doubt their brains,” said Lisa Mosconi, PhD, a neuroscientist at the Weill Cornell Women’s Brain Institute. “We go through puberty, and everybody is happy, then pregnancy, and it’s all parties and gifts and gender reveals. When you go through menopause, suddenly no one wants to hear about it.”
The data confirms that silence. A 2025 national survey by Biote found that nearly 40% of women seeking care for perimenopause symptoms reported being misdiagnosed. One-third were treated for anxiety, 27% for depression, and 13% for panic attacks. The M Factor 2025 Global Impact Report, the first data-driven exploration of how menopause affects women’s lives globally, found that 67% of women reported negative experiences with their providers, ranging from outright dismissal to physicians who simply lacked the knowledge to help. Nearly half endured symptoms for up to six years before recognizing them as menopause. Of those who sought treatment, 75% left untreated. Only 5% received evidence-based care.
Five percent. In a country that spends more on health care than any nation on earth.
Mosconi points to the biological stakes of that neglect. “Women are born with a ton of estrogen receptors, not just in the body but specifically in the brain,” she said. “Our brains run on estrogen starting at puberty, and they keep doing that until the end of our lives.” When that estrogen disappears and no one intervenes, the consequences extend far beyond discomfort.
The spiral no one talks about
For uninsured women, untreated menopause can dismantle financial stability entirely. When perimenopause unmasks conditions like ADHD, cognitive and executive function can deteriorate rapidly. A 2025 study published in European Psychiatry found that women with ADHD experienced more severe perimenopause symptoms and may begin experiencing them up to a decade earlier than women without it. Many are receiving their first neurodevelopmental diagnosis in their 40s and 50s, after a lifetime of coping strategies that hormonal decline has rendered useless. Job performance suffers. Employment becomes unstable. For women in midlife already contending with age discrimination in hiring, the next position, if it comes at all, often pays a fraction of what they earned before.
For women who were already uninsured or barely holding onto marketplace coverage, that instability pushes them further from care, not closer to it. Retirement savings get tapped early to cover basic expenses between jobs, and marketplace coverage, for those who had it, becomes dramatically less affordable. The Kaiser Family Foundation estimates that average out-of-pocket premiums for ACA marketplace enrollees more than doubled after enhanced premium tax credits expired on Jan. 1, 2026. A KFF survey found that 9% of previously enrolled marketplace consumers are now completely uninsured, and 55% of those who kept coverage have cut spending on food and clothing to afford premiums. The Congressional Budget Office projects 4 million people will lose coverage altogether. According to the National Women’s Law Center, 10 million of the 11.2 million women enrolled in ACA plans the prior year depended on those credits.
Community health centers and safety-net providers are not equipped for menopause-specific care. There are no federally funded programs designed to help uninsured women access hormone therapy, menopause specialists, or the lab work required to monitor treatment. The infrastructure does not exist. Every step of this spiral is connected. The system treats none of it as related.
The testosterone double standard
For uninsured women, the barriers compound further when it comes to testosterone. Women lose up to 50% of their natural testosterone by menopause, contributing to fatigue, diminished libido, muscle loss, and cognitive decline. The North American Menopause Society endorses its use for hypoactive sexual desire disorder. But there are zero FDA-approved testosterone products for women in the United States. There are more than 30 for men. Australia approved a female-specific product in 2020. The U.S. hasn’t established a regulatory pathway.
“Forty-three percent of women struggle with sexual dysfunction, and it’s like, why is there such a stigma?” said Somi Javaid, MD, board-certified OB-GYN, menopause and sexual health expert, and founder of HerMD. “Imagine if there was any other condition that affected 43% of women or men. Would we ignore it the way we do this?”
A woman seeking testosterone must first find one of the fewer than 1% of U.S. doctors certified in menopause care willing to prescribe off-label, then hope her pharmacist fills it. “I have had some pharmacists refuse to fill it because it isn’t FDA approved for the female population,” menopause care advocate Stacy London West told Rewire News Group. If she clears those hurdles, she pays $45 to over $100 per month out of pocket. For an uninsured woman already choosing between prescriptions and electricity, testosterone is not even on the table.
Where the safety net ends
In Missouri and Kansas, the gray area cuts deepest. Missouri expanded Medicaid in 2021, but MO HealthNet coverage of menopause care remains limited and does not cover treatment for sexual dysfunction. Kansas is one of only 10 states that still have not expanded Medicaid, leaving an estimated 28,000 residents in a coverage gap with no pathway to assistance. Neither state has introduced menopause-specific insurance legislation.
More than two dozen menopause bills were introduced across 18 states in 2025. California’s governor proposed comprehensive menopause coverage in his 2026-27 budget. Rhode Island enacted workplace protections. That momentum has not crossed the Mississippi River.
The economic toll is not abstract. A Mayo Clinic study estimated $26.6 billion in combined annual losses from menopause-related productivity declines and medical expenses. Research from Stanford University found that women who seek care for menopause symptoms earn 10% less four years later, a penalty heaviest for workers without college degrees. Black women are nearly three times more likely to report adverse work outcomes, and the disparities start earlier and last longer. The Study of Women’s Health Across the Nation found that Black women reach menopause 8.5 months earlier, experience symptoms for an average of 10 years compared to 6.5 for white women, and are significantly less likely to be prescribed hormone therapy despite a more severe need. For women in rural communities, where menopause-certified providers are virtually nonexistent, and the nearest specialist may be hours away, the gray area is not a gap but a void. The M Factor Global Impact Report documented 10% workforce attrition directly attributed to menopause.
The PBS documentary The M Factor: Shredding the Silence on Menopause and its sequel, The M Factor 2: Before the Pause, which premiered March 19, 2026, have brought these symptoms and realities to a national audience. “The neglect, ridicule, or shaming of debilitating symptoms is unacceptable and impacts more than just an individual woman’s well-being,” said Tamsen Fadal, Emmy Award-winning journalist and executive producer of the series.
For uninsured women, insurance was never in the picture to begin with. They are navigating a medical transition that affects every system in the body with no coverage, no specialist, no safety net, and a health care system that has spent decades telling them their symptoms are not real, not serious, or not worth investigating.
Wen Shen, MD, an OB-GYN at Johns Hopkins in Baltimore, offered a different vision of what this transition could be. “Menopause can actually be viewed as freedom,” she said. “Freedom from menstrual cycles, freedom from fear of getting pregnant. Women should celebrate the wisdom and knowledge that is gained from the decades lived and carry themselves with pride that she is someone that has made it through and has a lot to give.”
That freedom is real. But it is not equally distributed. For the millions of women trapped in the gray area, menopause is not a celebration of wisdom gained. It is a health crisis endured without help, one unpaid bill and one ignored symptom at a time.
They deserve more than a desk fan and a prayer.
